Lymphoma

Having all of these screenings for cancer terrifies me, even though they could be almost certainly nothing.

I was in disbelief when I was diagnosed with cancer, but then I turned my attention to crafting my surviving strategies.

I lived by Nike's motto, "Just do it!" and worked to gain my muscle back after cancer.

The anxiety of cancer will seemingly never go away.

Certain antihypertensive medications may lower blood pressure in patients with blood cancer being treated with Imbruvica or other BTK inhibitors.

Even my favorite show depicted cancer in a stereotypical way, which impacted my view on cancer when I first received my diagnosis of follicular lymphoma.

CURE® editors discuss last week’s biggest cancer headlines, from Dexter Scott King’s death to the potential of laughter therapy to boost quality of life.

From the Duchess of York receiving a skin cancer diagnosis to Selena Gomez contacting a fan with stage 4 disease, here’s what is happening in the oncology space this week.

A CAR NK therapy made from cord blood showed promising responses in patients with relapsed or refractory B-cell malignancies.

I've found that making time for a good laugh each day helped break through the looming thought of cancer.

The Food and Drug Administration is requesting that CAR-T cell therapies now come with a Boxed Warning about secondary malignancies that have been reported in patients who undergo these treatments.

A cancer-related side effect I faced was constipation caused by pain medication.

Certain tumor characteristics were predictive of which patients with lymphoma may have better outcomes with the CAR-T cell therapy, Yescarta.

The novel drug, IDP-023, is being investigated in patients with relapsed or refractory non-Hodgkin lymphoma or multiple myeloma.

When I told people I have follicular lymphoma, the first reaction I got is "At least you got a good cancer.”

A small study of iopofosine I 131 in patients with pretreated Waldenstrom’s macroglobulinemia showed that the disease control rate was 100%.

After being diagnosed with lymphoma, I decided to supplement my cancer treatment with turkey tail mushrooms.

Researchers have found the CAR-T cell therapy Breyanzi (lisocabtagene maraleucel) to be a cost-effective second-line treatment for patients with relapsed and refractory diffuse large B-cell lymphoma as the drug’s cost rises.

Experts look back on the year in the news regarding bispecific antibodies for the treatment of B-cell lymphomas including CLL and SLL.

The Food and Drug Administration has granted an Orphan Drug Designation to SLS009, a CDK9 inhibitor, for the treatment of patients with relapsed/refractory peripheral T-cell lymphomas.

Patients with relapsed/refractory large B-cell lymphoma treated with CAR-T cell therapy and bendamustine chemotherapy, experienced lower rates of survival and response as well as shorter times until progression, according to recent study findings.

I was asked if I celebrate my cancer journey dates... here is what I said.

Updated safety and subgroup analyses appear consistent with previously reported results from the phase 2 ZUMA-12 study of Yescarta for patients with high-risk large B-cell lymphoma.

Recently approved by the FDA for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), Jaypirca “represents a meaningful advance” in treatment, as one expert explained.

A novel cell therapy demonstrated early efficacy and an acceptable safety profile in patients with graft-versus-host disease undergoing haploidentical stem cell transplantation.